Pfizer’s Next Big Shot: COVID Levels Back on the Table?Huge Crisis or Groundbreaking Discovery?
This scenario suggests that once the running flat correction is completed — which we are very close to — the price is set to explode by at least 300% in the coming years (see red box).
Why do I think so?
• The running correction is approaching its final ta
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.89 USD
8.02 B USD
63.63 B USD
5.68 B
About Pfizer, Inc.
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
ISIN
US7170811035
FIGI
BBG000BR2B91
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Related stocks
PFE is forming a trough no questions asked! 3Ms is so oversold !Using only the Money flow index is dangerous game do your own analysis!...
The Money Flow Index (MFI) is a technical indicator that uses price and volume to identify overbought or oversold conditions in a security, similar to the Relative Strength Index (RSI) but incorporating volume data. It's a m
Pfizer's Weekly Supply Rejection Points to Possible TriggerPfizer Inc. recently retested a significant weekly supply zone, experiencing a rejection that suggests the market may revisit this level again. This retest could serve as a setup for a potential decline toward the daily demand area. Additionally, seasonal analysis indicates that the stock may contin
Pfizer May Be StallingPfizer has limped higher since April, but some traders may think the pharmaceutical giant is at risk of stalling.
The first pattern on today’s chart is the series of lower highs since January. PFE potentially just made another lower high at this falling trendline, which may suggest resistance is ta
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588589
Pfizer Investment Enterprises Pte. Ltd. 4.65% 19-MAY-2030Yield to maturity
—
Maturity date
May 19, 2030
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
—
Maturity date
May 19, 2053
P
PFE5588587
Pfizer Investment Enterprises Pte. Ltd. 4.45% 19-MAY-2026Yield to maturity
—
Maturity date
May 19, 2026
P
PFE5588591
Pfizer Investment Enterprises Pte. Ltd. 5.11% 19-MAY-2043Yield to maturity
—
Maturity date
May 19, 2043
P
PFE5588588
Pfizer Investment Enterprises Pte. Ltd. 4.45% 19-MAY-2028Yield to maturity
—
Maturity date
May 19, 2028
See all PFE bonds
Curated watchlists where PFE is featured.
Frequently Asked Questions
The current price of PFE is 23.87 USD — it has decreased by −3.98% in the past 24 hours. Watch Pfizer, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer, Inc. stocks are traded under the ticker PFE.
PFE stock has fallen by −2.85% compared to the previous week, the month change is a −3.54% fall, over the last year Pfizer, Inc. has showed a −19.30% decrease.
We've gathered analysts' opinions on Pfizer, Inc. future price: according to them, PFE price has a max estimate of 35.00 USD and a min estimate of 24.00 USD. Watch PFE chart and read a more detailed Pfizer, Inc. stock forecast: see what analysts think of Pfizer, Inc. and suggest that you do with its stocks.
PFE stock is 4.28% volatile and has beta coefficient of 0.45. Track Pfizer, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pfizer, Inc. there?
Today Pfizer, Inc. has the market capitalization of 135.71 B, it has decreased by −1.51% over the last week.
Yes, you can track Pfizer, Inc. financials in yearly and quarterly reports right on TradingView.
Pfizer, Inc. is going to release the next earnings report on Nov 4, 2025. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are 0.78 USD per share, whereas the estimation was 0.58 USD resulting in a 34.39% surprise. The estimated earnings for the next quarter are 0.71 USD per share. See more details about Pfizer, Inc. earnings.
Pfizer, Inc. revenue for the last quarter amounts to 14.65 B USD, despite the estimated figure of 13.56 B USD. In the next quarter, revenue is expected to reach 17.15 B USD.
PFE net income for the last quarter is 2.88 B USD, while the quarter before that showed 2.97 B USD of net income which accounts for −2.76% change. Track more Pfizer, Inc. financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was 0.43 USD. As of today, Dividend Yield (TTM)% is 7.16%. Tracking Pfizer, Inc. dividends might help you take more informed decisions.
Pfizer, Inc. dividend yield was 6.37% in 2024, and payout ratio reached 119.94%. The year before the numbers were 5.73% and 444.50% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 14, 2025, the company has 81 K employees. See our rating of the largest employees — is Pfizer, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pfizer, Inc. EBITDA is 25.68 B USD, and current EBITDA margin is 36.93%. See more stats in Pfizer, Inc. financial statements.
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer, Inc. stock shows the sell signal. See more of Pfizer, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.